Dynulta 2500 mg (Sucroferric oxyhydroxide)
| Active Ingredient | Sucroferric oxyhydroxide |
|---|---|
| Indication: | High phosphate levels in blood |
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Packaging | 6 Tablets in 1 Strip |
| Strength | 2500mg |
| Delivery Time | 6 To 15 days |
Dynulta 2500 mg contains Sucroferric Oxyhydroxide, an iron-based phosphate binder used to control serum phosphorus levels in patients with end-stage renal disease (ESRD) on dialysis. It binds dietary phosphorus in the gastrointestinal tract, reducing phosphate absorption. Dynulta has a chewable formulation, making it easy for patients with swallowing difficulties. Unlike calcium-based binders, it minimizes the risk of hypercalcemia. Common side effects include diarrhea, dark stools, or taste changes. Regular blood tests are necessary to monitor phosphate and iron levels. Take exactly as directed with meals for optimal effectiveness








There are no reviews yet.